학술논문

GSK356278, a potent, selective, brain-penetrant phosphodiesterase 4 inhibitor that demonstrates anxiolytic and cognition-enhancing effects without inducing side effects in preclinical species
Document Type
Article
Source
In: Journal of Pharmacology and Experimental Therapeutics. (Journal of Pharmacology and Experimental Therapeutics, July 2014, 350(1):153-163)
Subject
Language
English
ISSN
15210103
00223565